Global Non-Alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market
North America Market Analysis
North America non-alcoholic steatohepatitis therapeutics and diagnostics market is set to hold revenue share of over 36.8% by the end of 2037. The dominance of the region is attributed to the advanced healthcare infrastructure, a high prevalence rate of obesity and diabetes, and significant R&D investments by pharmaceutical companies. The U.S. and Canada are two leading markets in North America. Strong research institutions and supporting regulatory environments enhance the market potential of this region.
The U.S. is leading the non-alcoholic steatohepatitis therapeutics and diagnostics market due to the high prevalence of obesity and type 2 diabetes, which are two major risk factors for NAFLD/NASH. In addition, other ongoing drug development advances, such as the emergence of combination therapies, are being made to take care of unmet medical needs for a growing patient population. In March 2024, Max Biopharma and Metaba announced a collaboration on metabolomics studies to explore novel biomarkers and therapeutic targets for metabolic diseases, including NASH. Such partnerships aim to enhance the understanding of disease mechanisms and support the development of targeted treatments.
The non-alcoholic steatohepatitis therapeutics and diagnostics market in Canada is also steadily growing, along with increased awareness and investments in healthcare infrastructure. An increasing trend toward the integration of lifestyle management programs with pharmaceutical interventions reflects a holistic approach to addressing NASH. Government activities aimed at liver health and diseases associated with obesity also create a favorable climate for trying new methods of treatment. Furthermore, new diagnostic technologies are being presented to the market that are likely to enable better identification of patients and improve outcomes of treatment.
Asia Pacific Market Statistics
Asia Pacific non-alcoholic steatohepatitis (NASH) therapeutics and diagnostics market is predicted to grow at CAGR of over 28.8% through 2037, due to better access to healthcare, rising awareness, and proactively conducted screening programs. This growth is further supported by government programs regarding liver health and addressing non-communicable diseases. The large population base of the region and the growing burden of lifestyle-related diseases underpin its significant growth potential in the market.
India is anticipated to record considerable growth in the non-alcoholic steatohepatitis therapeutics and diagnostics market due to growing obesity, diabetes, and sedentary lifestyles among the population. Moreover, the increasing pharmaceutical industry in India facilitates cost-effective production with the distribution of therapeutics at economical rates, hence making treatments more accessible. For example, in July 2022, SRL Diagnostics launched the Fatty Liver Index test in India, which is a big leap toward early identification and management of liver disorders. Such innovations, along with rising efforts taken by the government to take control of metabolic disorders, are projected to drive market expansion.
The non-alcoholic steatohepatitis therapeutics and diagnostics market is expanding at a rapid pace in China due to increasing rates of obesity and diabetes in the country. The government's focus on improving access to healthcare and addressing chronic diseases should fuel further adoption of innovative therapies. Furthermore, partnerships among domestic pharmaceutical firms and international players promote drug development and NASH therapeutics and diagnostics market access. With significant investments in non-invasive diagnostic technologies, China is working to overcome the hurdles to early detection and treatment. As the country has a large pool of patients and increasing healthcare expenditure, there are several opportunities for players to expand.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?